Synthesis and biological evaluation of new cyclic amidine analogs of chlorambucil.

Article Details

Citation

Copy to clipboard

Bielawska A, Bielawski K, Muszynska A

Synthesis and biological evaluation of new cyclic amidine analogs of chlorambucil.

Farmaco. 2004 Feb;59(2):111-7.

PubMed ID

14871502 [ View in PubMed

]

Abstract

A number of novel cyclic amidine analogs of chlorambucil were synthesized and examined for cytotoxicity in breast cancer cell cultures and for inhibition of topoisomerases I and II. Evaluation of the cytotoxicity of these compounds employing a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and inhibition of [(3)H]-thymidine incorporation into DNA in both MDA-MB-231 and MCF-7 breast cancer cells demonstrated that these compounds were more active than chlorambucil. The degree to which these compounds inhibited cell growth breast cancer cells was directly correlated to DNA-binding affinity. These studies indicate that cyclic amidine analogs of chlorambucil are a potent catalytic inhibitor of topoisomerase II but not topoisomerase I. The highest degree of DNA binding and cytotoxicity in both MDA-MB-231 and MCF-7 breast cancer cells was observed for the compound, which possess a 4,5-dihydro-1H-imidazol moiety.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Chlorambucil	DNA	Nucleotide	Humans	Unknown	Cross-linking/alkylation	Details